$VDRM 0049!!? IS THE BEST PRODUCT VS PRICE in the whole

New Post Public Reply Private Reply Replies (1) Message Board
AAAAMHIM zigzagman #17692
$VDRM 0049!!? IS THE BEST PRODUCT VS PRICE in the whole country. THE BEST PENNYSTOCK IN America, and COULD BE THE pharmacy stock of the year. This stock can run 30,000% here's why.

1) EXTREMELY OVERSOLD and unknown 
2) ONLY 150 MILLION A\S! Makes it the TINIEST FLOAT VS PRICE out of ALL pharmacy stockso in the whole country!
3) Pharmaceutical stocks have the LARGEST PERCENTAGE GAINS OUT OF ALL STOCKS IN THE MARKET on the big boards or the OTHER. 
4) Unusual sudden MASSIVE increase in volume since 3/7/16 LOOK.
4) INSIDERS OWN 75 MILLION SHARES, that's right 75 MILLION!
5) WON AWARD FOR THEIR DRUG
6) STRONG HANDS HOLDING 11 million shares out of the TINY 18 million float.
7) After being silent for ages 4 JUICY FILINGS came out in September so something could be up.
8) THEY HAVE A PATENT which big boys have to be eyeing.

FELLAS PLEASE...PLEASE DO SOME RESEARCH ON THIS DRUG. VDRM IS A HIDDEN GOLDMINE

Lead Product TetraStem
World’s strongest broad spectrum tetracycline-based topical antibiotic with proven results.
Used for cuts, scrapes, wounds, infections, burns, acne, psoriasis, eczema, and minor injuries.
Very low water content and optimum (low) viscosity.
Uses both a chemical AND physical kill mechanism which is advantageous over traditional antibiotics which use only a chemical kill mechanism and has a better resistance profile.

Potential Markets
ViaDerma is developing products in many fields of use, including:
Topical antibiotics- $6 billion/year
Toenail antifungal drugs- $3 billion/year
Diabetic amputations- $3 billion/year
Global acne- $2.8 million in 2009, estimates of $3.02 billion by 2016
Psoriasis- $2.4 billion in 2010, estimates of over $7.3 billion by 2015
Eczema- $2.5 billion in 2014

Other potential markets include burns, anti-aging/wrinkle remover cream, medical cannabis, male-pattern baldness, skin cancer, erectile dysfunction, and pain management. Innovative, patent pending dual carrier transdermal technology which can transform oral medication into topical products.
Ability to enable active ingredients with a rapid transport direct to the site of action.

Ability to be used in any field including Sports Nutrition Supplements, Cosmetics, First Aid Products, Wound Care, and Skin Diseases like Acne, Eczema, and Psoriasis. Dual carrier liquid which can possess life enhancing technology with up to four year shelf-life.
Facilitates transfer of chemicals through the stratum corneum with a diffusion constant 10,000x higher. 


VDRM transdermal technology was used in a product which received the Bronze Award for “2012 Best New Pharmaceutical Product” at the 25th Annual Edison Awards in New York City
Named the winner of the “Drug Store News Best New Product” as voted by key pharmacy industry decision makers at the ECRM® Marketgate™ 2012 meetings held in Charlotte, NC. 

Strong Advanced Biological Coverage (ABC) which has higher concentrations, faster penetration and is more effective than conventional antibiotics. ABC produces desirable results in ~24 hours or less compared to 5-7 days. It kills all harmful gram-positive and gram-negative bacteria that have been available for testing. 

THIS IS NOT A REGULAR PENNY STOCK fellas. The LOWEST FLOAT vs price vs ALL PHARMA STOCKS IN THE COUNTRY. BIG BOARD OR OTC LAND. ALL OF THEM. Pharma stocks have the HIGHEST percentage gain in big boards or penny stocks.


Look at their product. LOOK AT WHAT THIS DRUG CAN DO! This is liquid gold IMO. The drug is unknown the stock is unknown but not for long http://www.viadermalicensing.com/img/ViaDermaCaseStudies.pdf
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Epsilor Launches Cutting-Edge 6T Battery for Military Use

Updated Category News Views 1

A Big Leap for Military Power on the Go Seems like Epsilor just raised the stakes in the military tech race with their latest 6T battery, a piece of kit boasting some serious muscle at 4,400Wh with 174Ah thrown in for good measure. Serving up a military-grade solution where endurance and performance are necessities, they've entered production just in time for the...

Continue Reading
STANLEY Dives Into Flooring: Strategic Move or Risky Bet?

Updated Category News Views 3

STANLEY® Floors: The New Frontier? Who would've thought STANLEY®, the tool giant founded back in 1843, would dive headfirst into the flooring market? This isn’t just any leap; it's a strategic handshake with Area Floors, and they’re dragging along i4F’s renowned drop-lock tech for good measure. What does this mean for the flooring landscape and STANLEY's brand...

Continue Reading
Vanda Pharmaceuticals Steps Into September Investor Talks

Updated Category News Views 2

Vanda Pharmaceuticals Heads Into Key Investor Spotlights In the relentless quest for market edge, Vanda Pharmaceuticals Inc. (NASDAQ: VNDA) is setting the stage for what could be some telling moments in September 2026. Investors with a keen interest in the pharmaceutical realm should seat themselves upfront as Vanda takes the floor in a series of pivotal conferences. Each...

Continue Reading
Codoxo Snags 2026 Award for AI Payment Innovation

Updated Category News Views 1

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Continue Reading
Epson and STOPware Reinvent Visitor Badges for Security

Updated Category News Views 12

Gone are the days when a flimsy monochrome badge was all that stood between a visitor and unrestricted access. Today, Epson and STOPware rock the boat with their new collaboration, offering a game-changing approach to security with full-color badge printing. This isn't just a vanity upgrade; it's about real security enhancement creating immediate visual cues. Shifting the...

Continue Reading
Corgi Re Modernizes Reinsurance with Tech-Focus

Updated Category News Views 2

Amidst the hullabaloo of the reinsurance world, Corgi Insurance is attempting something rather bold. They're flinging open the doors to innovation with a new brainchild, Corgi Re, promising to shake off the dust from an industry that still clings to the bygone era of spreadsheets and marathon underwriting cycles. The aim? Fire up modern underwriting technology and...

Continue Reading
Tolnai Joins UPCEA Leaders Pioneering Credential Innovations

Updated Category News Views 1

The Future of Education Shaped Today There's a profound shift happening in higher education, and it's not the usual undergrad grind most folks think of. Cate Tolnai, stepping into her role at the University of Phoenix, is in the thick of it. She's set to join the UPCEA Council for Credential Innovation's leadership team, and that isn't some fluff title. Her appointment...

Continue Reading
Mega Matrix Shares Consolidation Ahead: What It Means

Updated Category News Views 1

Quick and Unexpected Moves at Mega Matrix Just when you thought things couldn't get more complicated in the world of Mega Matrix Inc. (NYSE: MPU), they pull a rabbit out of the hat at their Extraordinary General Meeting on September 1st. Held at their office in Singapore, shareholders green-lighted some heavy-hitting changes like a share consolidation—twenty into one...

Continue Reading
Check Point Shareholders Back 2026 AGM Proposals

Updated Category News Views 0

Shareholder Endorsement Solidifies Check Point's Strategy Today, Check Point Software Technologies had a bit of a celebratory mood. Their stakeholders, it seems, aren't just riding the wave; they're all in. You could almost hear the cheers from Redwood City when those shareholder voting results flashed across the board. Some 81.2 million shares—encompassing about 79.52%...

Continue Reading
Costa Rica's Summit Draws Global Investors, Buyers

Updated Category News Views 0

Costa Rica's Big Stage for Business and Opportunity You might look at Costa Rica and think of lush rainforests and coffee beans, but right now, it's a hub bustling with suits, spreadsheets, and strategic meetings. Over three days, the Costa Rica Trade & Investment Summit (CRTIS) gathered nearly half a thousand buyers and investors all under one roof in San José. Local...

Continue Reading

Top 5 Most Recently Viewed Articles

BlackRock Moves Past 3% Stake in Syensqo, Notifications Issued

Updated Category News Views 186

BlackRock Inc. Participation Notification for Syensqo In a noteworthy development, BlackRock Inc. has recently communicated to Syensqo its participation status under Belgian transparency regulations, signaling a significant movement in their share ownership. The company has crossed the crucial 3% threshold, which triggers a notification requirement. Here’s a...

Continue Reading
Exploring the Bullish Trends in D-Wave Quantum's Options Trades

Updated Category News Views 262

Understanding D-Wave Quantum's Options Activity Recently, notable investors have exhibited a strong bullish sentiment towards D-Wave Quantum, signaling confidence in its future performance. When analyzing the options history for D-Wave Quantum (NYSE: QBTS), we identified a total of 21 trades. This activity reveals the mindset of investors which could be crucial for future...

Continue Reading
ECN Capital Moves Forward with Share Buyback Initiatives

Updated Category News Views 67

ECN Capital's Strategic Buyback Plans Approved ECN Capital Corp. (TSX: ECN) has recently received approval from the Toronto Stock Exchange (TSX) to begin normal course issuer bids for its common shares and Series C preferred shares. This strategic decision is aimed at effectively managing the company's equity structure while optimizing its cash resources. Understanding...

Continue Reading
Understanding Recent Updates on Cellectis Voting Rights

Updated Category News Views 130

Significant Updates on Cellectis Share Capital Cellectis is currently navigating through exciting timelines that focus on share capital and voting rights. As a prominent player in the gene editing industry, the company strives diligently to engage with its shareholders and keep them informed about the specifics of its capital structure. Market Listing and Share Details...

Continue Reading
Mallinckrodt plc Reports Strong Q3 Performance and Upgraded Guidance

Updated Category News Views 36

Mallinckrodt plc Financial Highlights Mallinckrodt plc, a global leader in specialty pharmaceuticals, has recently announced its financial outcome for the third quarter of the current fiscal year, demonstrating continued resilience and growth. With net sales reaching $505.5 million, marking a 1.7% increase compared to the same quarter last year, the company has reaffirmed...

Continue Reading